Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 362.22M | 366.51M | 408.37M | 385.37M | 250.16M | 247.10M |
Gross Profit | 60.39M | 62.10M | 80.01M | 91.53M | 45.10M | 43.44M |
EBITDA | 32.21M | 34.73M | 48.94M | 62.30M | 22.84M | 19.69M |
Net Income | 20.45M | 22.66M | 35.92M | 35.92M | 14.98M | 12.48M |
Balance Sheet | ||||||
Total Assets | 268.88M | 269.70M | 250.36M | 224.81M | 167.35M | 154.08M |
Cash, Cash Equivalents and Short-Term Investments | 67.46M | 75.88M | 62.61M | 37.03M | 28.62M | 16.95M |
Total Debt | 11.46M | 8.67M | 6.60M | 5.00M | 4.85M | 5.63M |
Total Liabilities | 58.48M | 54.47M | 54.78M | 60.84M | 45.53M | 49.81M |
Stockholders Equity | 210.41M | 215.23M | 195.57M | 163.97M | 121.82M | 104.28M |
Cash Flow | ||||||
Free Cash Flow | 18.57M | 21.54M | 33.01M | 16.35M | 16.16M | 5.79M |
Operating Cash Flow | 25.10M | 27.13M | 36.31M | 20.66M | 18.13M | 9.67M |
Investing Cash Flow | -6.43M | -1.97M | -2.41M | -6.47M | -1.95M | -4.23M |
Financing Cash Flow | -17.17M | -8.33M | -8.32M | -5.79M | -4.51M | -4.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | £4.33B | 19.71 | 4.92% | 5.59% | -3.22% | -37.21% | |
71 Outperform | £227.75M | ― | 4.80% | ― | ― | ||
70 Outperform | £61.87B | 19.37 | 15.72% | 1.61% | 2.11% | 3.37% | |
69 Neutral | £417.44M | 23.85 | 8.09% | 2.02% | -0.61% | 34.19% | |
62 Neutral | C$6.43B | 7.67 | 3.30% | 3.15% | 6.91% | -13.05% | |
56 Neutral | £599.88M | 39.58 | 3.80% | 2.41% | -9.77% | -28.49% |